• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

从 Evolut Pro 到 Evolut FX 自膨式经导管主动脉瓣置换系统：现状与未来展望。

From the Evolut Pro to the Evolut FX self-expanding transcatheter aortic valve replacement systems: current status and future perspectives.

机构信息

Department of Cardiology, Quebec Heart and Lung Institute, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, QC, Canada.

出版信息

Expert Rev Med Devices. 2022 Jul;19(7):561-569. doi: 10.1080/17434440.2022.2113386. Epub 2022 Aug 25.

DOI:10.1080/17434440.2022.2113386
PMID:36005274
Abstract

INTRODUCTION

Since the initial experience with the CoreValve (Medtronic, Minneapolis, Minnesota), there have been continuous iterations of this valve system in order to improve procedural success and reduce periprocedural complications. The Evolut Pro, Pro+, and FX are the latest generations of this transcatheter heart valve (THV).

AREAS COVERED

This review paper aims to analyze the main characteristics and clinical evidence about the Evolut Pro THV and summarize the main iterations of the newer generation Evolut FX valve system.

EXPERT OPINION

The Evolut Pro system has been associated with good clinical outcomes and excellent valve hemodynamic performance including reduced rates of paravalvular leaks. Technical enhancements to improve valve positioning, orientation, and vascular access have been implemented in the newer generation Evolut FX system.

摘要

简介

自最初使用 CoreValve（美敦力公司，明尼苏达州明尼阿波利斯市）以来，该瓣膜系统不断迭代更新，以提高手术成功率并减少围手术期并发症。Evolut Pro、Pro+ 和 FX 是该经导管心脏瓣膜（THV）的最新一代产品。

涵盖领域

本文旨在分析 Evolut Pro THV 的主要特点和临床证据，并总结新一代 Evolut FX 瓣膜系统的主要迭代。

专家意见

Evolut Pro 系统具有良好的临床结果和出色的瓣膜血流动力学性能，包括降低瓣周漏的发生率。在新一代 Evolut FX 系统中，采用了改进瓣膜定位、方向和血管入路的技术增强措施。

相似文献

1
From the Evolut Pro to the Evolut FX self-expanding transcatheter aortic valve replacement systems: current status and future perspectives.从 Evolut Pro 到 Evolut FX 自膨式经导管主动脉瓣置换系统：现状与未来展望。
Expert Rev Med Devices. 2022 Jul;19(7):561-569. doi: 10.1080/17434440.2022.2113386. Epub 2022 Aug 25.
2
Early experience with the Evolut FX self-expanding valve vs. Evolut PRO+ for patients with aortic stenosis undergoing TAVR.经导管主动脉瓣置换术中使用 Evolut FX 自膨式瓣膜与 Evolut PRO+ 治疗主动脉瓣狭窄患者的早期经验。
Cardiovasc Revasc Med. 2023 Nov;56:1-6. doi: 10.1016/j.carrev.2023.06.003. Epub 2023 Jun 5.
3
Three Generations of Self-Expanding Transcatheter Aortic Valves: A Report From the STS/ACC TVT Registry.三代自膨式经导管主动脉瓣：STS/ACC TVT 注册研究报告。
JACC Cardiovasc Interv. 2020 Jan 27;13(2):170-179. doi: 10.1016/j.jcin.2019.08.035.
4
Risk of Coronary Obstruction and Feasibility of Coronary Access After Repeat Transcatheter Aortic Valve Replacement With the Self-Expanding Evolut Valve: A Computed Tomography Simulation Study.经皮主动脉瓣置换术后重复使用自膨式 Evolut 瓣膜的冠状动脉阻塞风险和冠状动脉入路的可行性：计算机断层扫描模拟研究。
Circ Cardiovasc Interv. 2020 Dec;13(12):e009496. doi: 10.1161/CIRCINTERVENTIONS.120.009496. Epub 2020 Dec 4.
5
1-Year Outcomes With the Evolut R Self-Expanding Transcatheter Aortic Valve: From the International FORWARD Study.Evolut R 自膨式经导管主动脉瓣 1 年的结果：来自国际 FORWARD 研究。
JACC Cardiovasc Interv. 2018 Nov 26;11(22):2326-2334. doi: 10.1016/j.jcin.2018.07.032.
6
Improvements of Procedural Results With a New-Generation Self-Expanding Transfemoral Aortic Valve Prosthesis in Comparison to the Old-Generation Device.与旧一代装置相比，新一代自膨胀经股主动脉瓣假体在手术结果方面的改善。
J Interv Cardiol. 2017 Feb;30(1):72-78. doi: 10.1111/joic.12356. Epub 2016 Nov 24.
7
The Latest Evolution of the Medtronic CoreValve System in the Era of Transcatheter Aortic Valve Replacement: Matched Comparison of the Evolut PRO and Evolut R.美敦力 CoreValve 系统在经导管主动脉瓣置换时代的最新演进：Evolut PRO 和 Evolut R 的匹配比较。
JACC Cardiovasc Interv. 2018 Nov 26;11(22):2314-2322. doi: 10.1016/j.jcin.2018.07.023.
8
The Evolut R and Evolut PRO transcatheter aortic valve systems.Evolut R 和 Evolut PRO 经导管主动脉瓣系统。
Expert Rev Med Devices. 2019 Jan;16(1):3-9. doi: 10.1080/17434440.2019.1557045. Epub 2018 Dec 16.
9
Performance of the CoreValve Evolut R and PRO in Severely Calcified Anatomy: A Propensity Score Matched Analysis.CoreValve Evolut R 和 PRO 在重度钙化解剖结构中的性能：倾向评分匹配分析。
Heart Lung Circ. 2020 Dec;29(12):1847-1855. doi: 10.1016/j.hlc.2020.05.096. Epub 2020 Jun 16.
10
Procedural outcomes of the 34 mm EvolutR Transcatheter valve in a real-world population insights from the HORSE multicenter collaborative registry.34 毫米 EvolutR 经导管主动脉瓣在真实世界人群中的操作结果：来自 HORSE 多中心合作注册研究的启示。
Int J Cardiol. 2022 Aug 15;361:55-60. doi: 10.1016/j.ijcard.2022.04.079. Epub 2022 Apr 30.

引用本文的文献

1
Neo-Commissural Alignment by Withdrawing and Readvancing the Delivery System during Transcatheter Aortic Valve Replacement with Self-Expanding Prosthesis.经导管主动脉瓣置换术中自膨式瓣膜输送系统回撤和前送实现 Neo-Commissural Alignment
J Interv Cardiol. 2023 Dec 11;2023:1060481. doi: 10.1155/2023/1060481. eCollection 2023.
2
Predictors of Conduction Disturbances Requiring New Permanent Pacemaker Implantation following Transcatheter Aortic Valve Implantation Using the Evolut Series.使用Evolut系列经导管主动脉瓣植入术后需要植入新的永久性起搏器的传导障碍预测因素。
J Clin Med. 2023 Jul 22;12(14):4835. doi: 10.3390/jcm12144835.
3
Personalised Treatment in Aortic Stenosis: A Patient-Tailored Transcatheter Aortic Valve Implantation Approach.
主动脉瓣狭窄的个性化治疗：一种针对患者的经导管主动脉瓣植入方法。
J Cardiovasc Dev Dis. 2022 Nov 21;9(11):407. doi: 10.3390/jcdd9110407.